About Penta
Who we are
Our Strategy
Our Network
Working Groups
Penta Foundation
Our Staff
Diversity and Inclusion
Annual reports
Our Activities
News & Webinars
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
Looking ahead to 2026
Putting families at the heart of neonatal sepsis research through SNIP-AFRICA
Strengthening paediatric HIV care through THRIVE training
Strengthening responsible research through NIS2 cyber‑resilience
Building preparedness by including those most often left behind through the PIPELINE project
From emergency response to preparedness. The VERDI legacy
Completing the EPPICC Dolutegravir study to advance evidence for paediatric HIV care
Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy
Malattie infettive: la rete globale per la salute di mamme e bambini
Dolutegravir as first- or second-line treatment for children living with HIV: 240-week follow-up of the ODYSSEY randomised trial
Mpox in Children and Adolescents
Kangaroo Care as an intervention in randomised controlled trials in neonatal intensive care